Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Holding(s) in Company

19 Oct 2007 13:55

MicroEmissive Displays Group PLC19 October 2007 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached MICROEMISSIVE DISPLAYS GROUP PLC 2. Reason for the notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights ( ) An acquisition or disposal of financial instruments which may ( ) result in the acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights ( ) Other (specify): Change in issued share capital (X) 3. Full name of person(s) subject to the notification obligation: AXA S.A. 25 Avenue Matignon, 75008 Paris and its group of companies 4. Full name of shareholder(s) (if different from 3.) 5. Date of the transaction (and date on which the threshold is crossed or reached if different): 15/10/2007 6. Date on which issuer notified: 16/10/2007 7. Threshold(s) that is/are crossed or reached: 10% 8. Notified details: Share placement A. Voting rights attached to shares Class/type of shares (if possible using the Ordinary (GB00B0346S80)ISIN code) Situation previous to Resulting situation after the triggering transaction the triggering transactionNumber of Number of Number of Number of voting % of voting rightsShares Voting shares rights Rights Direct Direct Indirect Direct Indirect4,875,000 4,875,000 0 0 6,075,000 0.00% 10.24% B. Financial Instruments Resulting situation after the triggering transactionType of Expiration Exercise/ Number of voting % of votingfinancial date Conversion Period/ rights that may rightsinstrument Date be acquired if the instrument is exercised/ converted Total (A+B)Number of voting rights % of voting rights6,075,000 10.24% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: Name of Company / Fund Number of Shares % of issued share capital Framlington Goldmans 200,000 0.33697% AXA Framlington SEI UK Equity 791,666 1.33384% (Indirect) AXA Framlington Throgmorton 3,150,000 5.30730% Trust (Indirect) AXA Framlington UK Smaller 1,933,334 3.25739% Companies (Indirect) Total (indirect) 6,075,000 10.23551% Proxy Voting:10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: 14: Contact name: Terry Marsh 15. Contact telephone number: 020 7003 2637 This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.